Anita Lettenbichler

Title: Anita Lettenbichler: Innovator in Pharmaceutical Modifications

Introduction

Anita Lettenbichler is a notable inventor based in Innsbruck, Austria. She has made significant contributions to the field of pharmaceuticals, particularly with her innovative work on Lifibrol. Her research and development efforts have led to advancements that enhance the formulation and stability of pharmaceutical products.

Latest Patents

Anita Lettenbichler holds a patent for a new modification of Lifibrol. This modification is characterized by a melting point ranging from 132°C to 138°C, with a preferred range of 134°C to 136°C. The primary peak in the IR spectrum is observed at a wave number of 3,200-3,400, ideally at 3,250-3,350. This new modification, referred to as modification II, allows for improved crystallization, enabling large-scale industrial formulation of tablets that are both stable and of acceptable size.

Career Highlights

Anita is associated with Klinge Pharma GmbH, where she applies her expertise in pharmaceutical sciences. Her work has been instrumental in developing formulations that meet industry standards and improve patient outcomes.

Collaborations

Anita collaborates with colleagues such as Artur Burger and Fritz Stanislaus, contributing to a dynamic team focused on pharmaceutical innovation.

Conclusion

Anita Lettenbichler's contributions to the field of pharmaceuticals, particularly through her patent on Lifibrol, highlight her role as an innovator. Her work continues to influence the industry and improve the formulation of essential medications.